“SGLT2 Inhibitors: Cardiorenal Mechanisms How a glucose-lowering drug became a foundational heart and kidney therapy”, d, vol. 4, no. 14, pp. 28–29, Jul. 2026, Accessed: Sep. 17, 2026. [Online]. Available: https://www.thediabzen.com/index.php/d/article/view/54